Association of Interleukin-6 −174 G>C Promoter Polymorphism with Increased Risk of Type 2 Diabetes Mellitus Patients with Diabetic Nephropathy in Turkey

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Genetic Testing and Molecular Biomarkers

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/gtmb.2013.0357PMID 24102240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.

  2004cited by this paper
• The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.

  2004cited by this paper
• Linkage and association mapping of a chromosome 1q21-q24 type 2 diabetes susceptibility locus in northern European Caucasians.

  2004cited by this paper
• The interleukin-6 (−174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians

  2003cited by this paper
• Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females.

  2003cited by this paper
• Interleukin‐6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in Type 2 diabetes

  2002cited by this paper
• Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation*

  2000cited by this paper
• The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients.

  2000cited by this paper
• Interleukin-6 gene polymorphism and insulin sensitivity.

  2000cited by this paper
• Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects.

  2000cited by this paper
• A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.

  1999cited by this paper
• Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women

  1999cited by this paper
• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

  1998influential reference
• Adipose tissue as an endocrine and paracrine organ

  1998cited by this paper
• Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.

  1997cited by this paper
• Polymorphisms in the Interleukin-1 Gene Cluster Do Not Contribute to the Genetic Susceptibility of Diabetic Nephropathy in Caucasian Patients With IDDM

  1997cited by this paper
• In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy

  1995cited by this paper
• Detection of serum IL-6 in patients with diabetic nephropathy.

  1994cited by this paper
• Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.

  1994cited by this paper
• The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human Monocytes

  1994cited by this paper
• Interleukin-6: an autocrine regulator of mesangial cell growth.

  1992cited by this paper
• Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM

  1992cited by this paper
• Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.

  1992cited by this paper
• Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8.

  1991cited by this paper
• Interleukin 6 is an autocrine growth factor for mesangial cells.

  1990cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper

• Impact of tumor necrosis factor-α and interleukin 6 polymorphisms on type 2 diabetes mellitus Sudanese patients

  2025cites this paper
• Frequency of Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10 Gene Polymorphisms in Mexican Patients with Diabetic Retinopathy and Diabetic Kidney Disease

  2025cites this paper
• Association of IL-4 (− 590 C/T) and IL-6 (− 174 G/C) gene polymorphism in South Indian CKD patients

  2024cites this paper
• Associations between the polymorphisms of main components in PI3K/Akt pathway and risk of diabetic kidney disease: A meta‐analysis

  2023cites this paper
• Case–control study on TP73 rs1801173 C > T gene polymorphism and susceptibility to gastric cancer in a Chinese Han population

  2022cites this paper
• IL-6 gene rs1800795 polymorphism and diabetes mellitus: a comprehensive analysis involving 42,150 participants from a meta-analysis

  2022cites this paper
• Meta‐analysis: Interleukin 6 gene ‐174G/C polymorphism associated with type 2 diabetes mellitus and interleukin 6 changes

  2021cites this paper
• Association between polymorphisms of cytokine genes and diabetic nephropathy: A comprehensive systematic review and meta‐analysis

  2021cites this paper
• The association of interieukin-6 polymorphism (rs1800795) with microvascular complications in Type 2 diabetes mellitus

  2020cites this paper
• Association Between IL-6 Polymorphisms and Diabetic Nephropathy Risk: A Meta-analysis.

  2019cites this paper
• Association of Interleukin-6 -174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes: A Meta-analysis

  2019cites this paper
• Association of the Interleukin-6 rs1800795 Polymorphism with Type 2 Diabetes Mellitus in the Population of the Island of Crete, Greece

  2018cites this paper
• Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.

  2018cites this paper
• CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients.

  2018cites this paper
• The relationship of the endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) gene polymorphism in Turkish type 2 diabetic patients with and without diabetic foot ulcers.

  2018cites this paper
• Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update

  2017cites this paper
• Genetic variations in interleukin 6 rs1800795 polymorphism and the association with susceptibility to Hashimoto's thyroiditis

  2017cites this paper
• Association between interleukin-6-174 G > C and-634 C > G polymorphism and diabetic nephropathy : a meta-analysis

  2017cites this paper
• The relationship of Interleukin-6 -174 G>C gene polymorphism in type 2 diabetic patients with and without diabetic foot ulcers in Turkish population.

  2017cites this paper
• Effect of G(-174)C polymorphism in interleukin-6 gene on cardiovascular disease in type 2 diabetes patients.

  2016cites this paper
• Lack of association between rs1800795 (-174 G/C) polymorphism in the promoter region of interleukin-6 gene and susceptibility to type 2 diabetes in Isfahan population

  2016cites this paper
• The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 Diabetic Patients with and without diabetic foot ulcers.

  2016cites this paper
• Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility

  2016cites this paper
• Role of interleukin-6 polymorphisms in the development of allergic rhinitis.

  2016cites this paper
• Gene Polymorphisms in the RANKL/RANK/OPG Pathway Are Associated with Type 2 Diabetes Mellitus in Southern Han Chinese Women

  2016cites this paper
• Gene-gene, gene-environment, gene-nutrient interactions and single nucleotide polymorphisms of inflammatory cytokines.

  2015cites this paper
• Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes Patients

  2015cites this paper
• Association of single nucleotide polymorphism of inflammatory cytokines with type 2 diabetes mellitus in patients reporting to tertiary care hospital in Pakistan

  2015influential citation
• T-Cell Cytokine Gene Polymorphisms and Vitamin D Pathway Gene Polymorphisms in End-Stage Renal Disease due to Type 2 Diabetes Mellitus Nephropathy: Comparisons with Health Status and Other Main Causes of End-Stage Renal Disease

  2014cites this paper